Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs
Metadata
Title
Correction to: Fostemsavir: First Approval
Author
Anthony Markham
Publication date
01-10-2020
Publisher
Springer International Publishing
Keyword
Fostemsavir
Published in
Drugs / Issue 15/2020
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-020-01403-y

Other articles of this Issue 15/2020

Drugs 15/2020 Go to the issue

Review Article

Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs

AdisInsight Report

Triheptanoin: First Approval

AdisInsight Report

Belantamab Mafodotin: First Approval

Leading Article

Movement of Poly-ADP Ribose (PARP) Inhibition into Frontline Treatment of Ovarian Cancer

Adis Drug Evaluation

Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer

Adis Drug Evaluation

Atezolizumab: A Review in Extensive-Stage SCLC